Literature DB >> 20211852

Serial measurement of the N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts poor outcome in a patient with congenitally corrected transposition of the great arteries (ccTGA).

Tanja M Raedle-Hurst1, Meryem Hosse, Hashim Abdul-Khaliq.   

Abstract

The usefulness of natriuretic peptides to assess myocardial function in patients with a systemic morphological right ventricle is still unclear. In this report we describe the clinical course of a young woman with congenitally corrected transposition of the great arteries (ccTGA) who suffered from a progressive deterioration of myocardial function after child birth despite intensive medical treatment and additional cardiac resynchronization therapy. In this woman, serial measurement of NT-proBNP levels was related to the velocity time integral over the aortic valve and indicated worsening of the patient's haemodynamic status and finally death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211852     DOI: 10.1093/eurjhf/hfq033

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  1 in total

1.  B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle.

Authors:  Marketa Hegarova; Jaroslav Brotanek; Milos Kubanek; Radka Kockova; Janka Franekova; Vera Lanska; Ivan Netuka; Vojtech Melenovsky; Ivan Malek; Josef Kautzner
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.